- Tytuł:
- [A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy].
- Autorzy:
- Źródło:
- Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova [Zh Vyssh Nerv Deiat Im I P Pavlova] 2016 Sep; Vol. 66 (5), pp. 515-540.
- Typ publikacji:
- Journal Article; Review
- Język:
- Russian
- Imprint Name(s):
-
Publication: Moscow : Izd-Vo Akademiia Nauk Ssr
Original Publication: Moscow, Izd-vo Akademiia nauk SSR. - MeSH Terms:
-
Alzheimer Disease/*drug therapy
Autophagy/*drug effects
Huntington Disease/*drug therapy
Molecular Targeted Therapy/*methods
Neuroprotective Agents/*therapeutic use
Parkinson Disease/*drug therapy
Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Amyloid beta-Peptides/genetics ; Amyloid beta-Peptides/metabolism ; Animals ; Autophagy/genetics ; Clinical Trials as Topic ; Gene Expression Regulation ; Humans ; Huntingtin Protein/genetics ; Huntingtin Protein/metabolism ; Huntington Disease/genetics ; Huntington Disease/metabolism ; Huntington Disease/pathology ; Metformin/therapeutic use ; Molecular Chaperones/genetics ; Molecular Chaperones/metabolism ; Parkinson Disease/genetics ; Parkinson Disease/metabolism ; Parkinson Disease/pathology ; Proteasome Endopeptidase Complex/drug effects ; Proteasome Endopeptidase Complex/metabolism ; Sirolimus/therapeutic use ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; Ubiquitin/genetics ; Ubiquitin/metabolism ; alpha-Synuclein/genetics ; alpha-Synuclein/metabolism - Substance Nomenclature:
-
0 (Amyloid beta-Peptides)
0 (HTT protein, human)
0 (Huntingtin Protein)
0 (Molecular Chaperones)
0 (Neuroprotective Agents)
0 (Ubiquitin)
0 (alpha-Synuclein)
9100L32L2N (Metformin)
EC 2.7.1.1 (MTOR protein, human)
EC 2.7.11.1 (TOR Serine-Threonine Kinases)
EC 3.4.25.1 (Proteasome Endopeptidase Complex)
W36ZG6FT64 (Sirolimus) - Entry Date(s):
- Date Created: 20190130 Date Completed: 20190219 Latest Revision: 20211204
- Update Code:
- 20240104
- PMID:
- 30695399
- Czasopismo naukowe